+1 862-686-2696
Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Cell Culture Media, Kits & Reagents
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Primary Cells

Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated)

  • For research use only

Cat No.

ABC-TC3006
Product Type

Blood Products
Cell Type

Plasma
Species

Human
Growth Conditions

37 ℃, 5% CO2
Source Organ

Bone Marrow
Disease

Acute Lymphoid Leukemia
Storage

Liquid Nitrogen

Human Acute Lymphoid Leukemia Bone Marrow Plasma offers a leukemia-specific biofluid for biomarker detection, cytokine analysis, and hematologic profiling.

Product Image
  • Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated)
Get a Quote
Home | Primary Cells | Human Primary Cells | Blood System Primary Cells | Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated)

Description

Human Acute Lymphoid Leukemia Bone-Marrow Plasma is an acellular plasma fraction prepared from bone marrow aspirates of adult patients diagnosed with acute lymphoblastic leukemia (ALL), providing a model of untreated leukemia plasma signature. This product contains soluble mediators and extracellular vesicles derived from the leukemic bone marrow microenvironment, making it suitable for investigating leukemic signaling, progenitor-cell responses, and plasma proteomics in leukemia research, as well as tumor–microenvironment interactions. To ensure the quality of these primary cells, repeated freeze-thaw cycles are not recommended due to the fragile nature of these cells. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated), ALL BM plasma ND/UT, Human ALL BM plasma
Species

Human
Cat.No

ABC-TC3006
Product Category

Primary Cells
Size/Quantity

1 vial
Cell Type

Plasma
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Source Organ

Bone Marrow
Disease

Acute Lymphoid Leukemia
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Blood Products
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) is ideal for research on leukemia microenvironment, cytokine signaling, proteomics, metabolomics, and liquid biopsy assay development. It enables analysis of cell-free RNA/DNA, supports biomarker discovery and validation, and is well-suited for immune profiling, drug response monitoring, and understanding minimal residual disease (MRD). The plasma can be applied in platforms such as ELISA, multiplex assays, qPCR, and RNA-Seq, making it a valuable non-cellular tool for hematologic malignancy studies.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

  • Online Inquiry
  • Product Reviews

Inquiring Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button